KIDS ORTHOPEDIATRICS

Ownership history in MARSHALL WACE, LLP  ·  10 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ORTHOPEDIATRICS (KIDS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q2)
Avg. % of fund
0.01%
First filed
2019 Q1
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 444,320 +25,191 +6.0% 0.01% $8.2M $18.53
2025 Q2 ADDED 419,129 +63,345 +17.8% 0.01% $9.0M $21.48
2025 Q1 ADDED 355,784 +299,882 +536.4% 0.01% $8.8M $24.63
2024 Q1 ADDED 55,902 +50,305 +898.8% 0.00% $1.6M $29.16
2023 Q2 REDUCED 5,597 -10,525 -65.3% 0.00% $245K $43.85
2022 Q4 ADDED 16,122 +7,989 +98.2% 0.00% $641K $39.73
2021 Q1 ADDED 8,133 +3,126 +62.4% 0.00% $396K $48.75
2020 Q4 REDUCED 5,007 -39,908 -88.9% 0.00% $207K $41.25
2020 Q2 ADDED 44,915 +35,238 +364.1% 0.01% $2.0M $43.76
2019 Q1 INITIATED 9,677 0.00% $428K
% of Fund (quarterly)    KIDS price (monthly, adj. close)
← Back to MARSHALL WACE, LLP Holdings